https://oncologypodcast.simplecast.com 2026-04-02 1 https://oncologypodcast.simplecast.com/episodes 2026-04-02 0.9 https://oncologypodcast.simplecast.com/episodes/experts-discuss-adcs-for-her2-negative-ultralow-low-mbc-rXxfzGFZ 2026-04-02 0.8 https://oncologypodcast.simplecast.com/episodes/advanced-practice-professionals-on-biomarker-testing-in-patients-with-solid-tumors-colorectal-cancer-H9QtAE7a 2026-03-24 0.8 https://oncologypodcast.simplecast.com/episodes/advanced-practice-professionals-on-biomarker-testing-in-patients-with-solid-tumors-prostate-cancer-gPEubEaL 2026-03-24 0.8 https://oncologypodcast.simplecast.com/episodes/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026-VT2A9cW5 2026-03-23 0.8 https://oncologypodcast.simplecast.com/episodes/myth-vs-medicine-pharmacists-perspective-on-adjuvant-cdk4-6-inhibitor-optimization-EWbEJ_1v 2026-03-12 0.8 https://oncologypodcast.simplecast.com/episodes/from-ash-2025-to-the-clinic-global-perspectives-on-evolving-btk-therapies-in-relapsed-refractory-cll-dk0fFFb5 2026-03-11 0.8 https://oncologypodcast.simplecast.com/episodes/2025-sabcs-cf-highlights-_U7HKSWV 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions-b5W8lj1w 2026-04-08 0.8 https://oncologypodcast.simplecast.com/episodes/beyond-chemotherapy-in-all-emerging-bispecific-antibodies-car-t-cell-therapies-and-evolving-treatment-strategies-lmuNnyTt 2026-02-27 0.8 https://oncologypodcast.simplecast.com/episodes/ras-inhibitors-for-pdac-lY5Ir7hc 2026-02-23 0.8 https://oncologypodcast.simplecast.com/episodes/biomarker-testing-lung-cancer-96hfRekH 2026-04-07 0.8 https://oncologypodcast.simplecast.com/episodes/individualized-hemophilia-care-with-hemostatic-rebalancing-therapies-dqdV3hYn 2026-01-30 0.8 https://oncologypodcast.simplecast.com/episodes/experts-offer-guidance-on-shared-decision-making-in-the-management-of-patients-with-pv-et-76gbHrvr 2026-01-21 0.8 https://oncologypodcast.simplecast.com/episodes/celmod-agents-in-mm-t__Fv414 2026-02-27 0.8 https://oncologypodcast.simplecast.com/episodes/pulsecast-mds-mpns-ash-2025-gjgMSLvH 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/expert-highlights-from-the-2025-world-conference-on-lung-cancer-xtL7XH1F 2025-12-24 0.8 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-multiple-myeloma-from-the-2025-ash-annual-meeting-8QYrWSjK 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-lymphomas-from-the-2025-ash-annual-meeting-81opm6P_ 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-nonmalignant-blood-disorders-from-the-2025-ash-annual-meeting-zWdQzhSF 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-leukemias-from-the-2025-ash-annual-meeting-skBpct_b 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/trop2-tigit-for-nsclc-Ohj3sd13 2025-11-18 0.8 https://oncologypodcast.simplecast.com/episodes/new-targeted-combination-for-lgsoc-4wKKnX5N 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/cdh6-adcs-GtXXAtTO 2026-03-27 0.8 https://oncologypodcast.simplecast.com/episodes/immunotherapy-in-cscc-_r1fTTyb 2026-03-11 0.8 https://oncologypodcast.simplecast.com/episodes/modern-management-of-pnh-CVZ8PPvL 2026-03-26 0.8 https://oncologypodcast.simplecast.com/episodes/ebc-care-6ZFtVPLf 2026-02-17 0.8 https://oncologypodcast.simplecast.com/episodes/mbc-care-lWQSrK4f 2026-02-17 0.8 https://oncologypodcast.simplecast.com/episodes/treatment-of-her2pos-gea-and-btc-rQi8W8yC 2026-02-27 0.8 https://oncologypodcast.simplecast.com/episodes/bispecific-antibodies-for-fl-oQWBxxCZ 2025-09-11 0.8 https://oncologypodcast.simplecast.com/episodes/pancreatic-cancer-progress-podcast-QbbAcnf_ 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/latest-car-t-advances-4Fptxr3T 2025-09-03 0.8 https://oncologypodcast.simplecast.com/episodes/cdk46-inhibitors-in-breast-cancer-zXtfYqrf 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/targeting-dll3-for-ep-necs-rnBn0K9t 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/subcutaneous-io-podcast-cbwpysxW 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/nhl-all-from-eha-icml-2025-0iB6gGNT 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/asco-2025-breast-cancer-yTq8KjtN 2025-07-25 0.8 https://oncologypodcast.simplecast.com/episodes/her2-positive-mbc-new-options-hkcRyxCI 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/menin-inhibitors-in-aml-UNSQ3it_ 2025-07-24 0.8 https://oncologypodcast.simplecast.com/episodes/btki-in-cll-2025-updates-BZ77P6Al 2025-07-23 0.8 https://oncologypodcast.simplecast.com/episodes/immunotherapy-for-hcc-z9_qLkwS 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/hodkin-lymphoma-frontline-tx-k3Eik1yd 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/celmods-in-myeloma-08Po1z_N 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/role-of-the-multidisciplinary-team-in-achieving-comprehensive-and-individualized-care-of-patients-with-hr-positive-her2-negative-metastatic-breast-cancer-and-preexisting-comorbidities-1e9ZzWZO 2025-05-29 0.8 https://oncologypodcast.simplecast.com/episodes/her2-adcs-safety-and-tolerability-RNLUQdZr 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/her2-targeted-adcs-clinical-data-GObe0J_L 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/b7-h3-sclc-fnwK67gi 2025-04-24 0.8 https://oncologypodcast.simplecast.com/episodes/her2-targeted-adcs-in-solid-tumors-hmyHtaoK 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/1l-her2-positive-mbc-u6mKk8Hu 2026-02-03 0.8 https://oncologypodcast.simplecast.com/episodes/cdk4-6-inhibitors-for-breast-cancer-QkfLaidR 2025-02-20 0.8 https://oncologypodcast.simplecast.com/episodes/bsabs-in-rrmm-key-updates-t9QTrOrq 2025-02-10 0.8 https://oncologypodcast.simplecast.com/episodes/oral-serds-for-hr-her2-neg-esr1m-mbc-vW87_xp1 2025-01-16 0.8 https://oncologypodcast.simplecast.com/episodes/bispecific-antibodies-in-r-r-mm-CAsMd17_ 2024-10-22 0.8 https://oncologypodcast.simplecast.com/episodes/gep-nets-podcast-amQntHfi 2024-10-16 0.8 https://oncologypodcast.simplecast.com/episodes/esmo-2024-gyn-cancers-QzBGIWm4 2024-10-01 0.8 https://oncologypodcast.simplecast.com/episodes/understanding-btk-inhibitor-resistance-in-cll-rBnJBjc9 2024-09-30 0.8 https://oncologypodcast.simplecast.com/episodes/progressive-ros1-altered-advanced-nsclc-d9pZi_Gv 2024-09-06 0.8 https://oncologypodcast.simplecast.com/episodes/first-line-data-for-ros1-altered-advanced-nsclc-FMQ6vbOM 2024-09-05 0.8 https://oncologypodcast.simplecast.com/episodes/iros1-i-alterations-and-molecular-testing-in-advanced-nsclc-P9anCwQK 2024-08-28 0.8 https://oncologypodcast.simplecast.com/episodes/midyear-highlights-gyn-cancers-yB3Ncjvo 2024-08-05 0.8 https://oncologypodcast.simplecast.com/episodes/spotlight-on-serds-in-breast-cancer-V6ICDa5E 2024-07-22 0.8 https://oncologypodcast.simplecast.com/episodes/podcast-cll-sll-guidelines-eaf1MEQv 2024-07-18 0.8 https://oncologypodcast.simplecast.com/episodes/emerging-data-for-mpns-Qn1OiZYu 2024-07-12 0.8 https://oncologypodcast.simplecast.com/episodes/podcast-celmods-in-lymphomas-nqIJ3lbY 2024-07-11 0.8 https://oncologypodcast.simplecast.com/episodes/cdk4-6-inhibition-in-breast-cancer-kJOrjNMK 2024-07-09 0.8 https://oncologypodcast.simplecast.com/episodes/emerging-data-for-aml-C0kb0FpB 2024-07-08 0.8 https://oncologypodcast.simplecast.com/episodes/emerging-data-for-mds-JZElLk7T 2024-07-05 0.8 https://oncologypodcast.simplecast.com/episodes/oral-serds-for-mbc-g7M97D7w 2024-05-14 0.8 https://oncologypodcast.simplecast.com/episodes/applying-cll-guidelines-k2OgVTUL 2024-05-07 0.8 https://oncologypodcast.simplecast.com/episodes/hrr-testing-podcast-na1yfWyd 2024-03-28 0.8 https://oncologypodcast.simplecast.com/episodes/novel-adcs-in-advanced-breast-cancer-2eaTIgyP 2024-03-18 0.8 https://oncologypodcast.simplecast.com/episodes/ae-management-for-her3-targeted-tx-STkudeTi 2023-12-26 0.8 https://oncologypodcast.simplecast.com/episodes/her3-trials-in-nsclc-epAFcP2Q 2023-12-26 0.8 https://oncologypodcast.simplecast.com/episodes/rationale-for-targeting-her3-in-nsclc-615H5ddp 2023-12-26 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-seminal-new-clinical-trial-data-presented-at-the-2023-igcs-conference-informing-treatment-for-endometrial-ovarian-and-cervical-cancers-bx8wwA6m 2023-12-04 0.8 https://oncologypodcast.simplecast.com/episodes/novel-emerging-investigational-treatment-strategies-for-patients-with-myelofibrosis-j7tCfHSO 2023-11-30 0.8 https://oncologypodcast.simplecast.com/episodes/a-year-in-review-and-a-look-to-the-future-btki-in-cll-and-mcl-7nFWWF12 2023-11-20 0.8 https://oncologypodcast.simplecast.com/episodes/key-data-from-esmo-2023-SgyuJKkw 2023-11-17 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-and-considerations-for-precision-care-with-her3-targeted-agents-in-nsclc-and-breast-cancer-Ye0Nv878 2023-11-07 0.8 https://oncologypodcast.simplecast.com/episodes/improving-care-for-black-patients-with-endometrial-cancer-1t_wppZ7 2023-11-06 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-key-updates-and-new-clinical-trial-data-from-the-esgo-2023-congress-informing-treatment-for-cervical-ovarian-and-endometrial-cancers-az_hl2LD 2023-10-13 0.8 https://oncologypodcast.simplecast.com/episodes/new-evidence-with-btk-inhibitor-therapy-in-cll-and-mcl-from-soho-2023-nXiIzX9b 2023-10-04 0.8 https://oncologypodcast.simplecast.com/episodes/btki-therapy-for-mcl-icml-2023-gStRtnln 2023-08-17 0.8 https://oncologypodcast.simplecast.com/episodes/btki-therapy-for-cll-eha-2023-umaYgoIo 2023-07-28 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-key-updates-and-new-clinical-trial-data-from-the-2023-asco-annual-meeting-informing-treatment-for-cervical-ovarian-and-endometrial-cancers-I5AJjbEp 2023-06-22 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-new-data-from-sgo-2023-informing-treatment-for-endometrial-cervical-and-ovarian-cancers-gTR885Et 2023-05-04 0.8 https://oncologypodcast.simplecast.com/episodes/practical-insights-on-using-bcma-targeted-therapies-in-multiple-myeloma-72bW3p_z 2023-04-26 0.8 https://oncologypodcast.simplecast.com/episodes/management-of-mf-ceCKT8yZ 2023-04-11 0.8 https://oncologypodcast.simplecast.com/episodes/brca-testing-and-adjuvant-therapy-in-ebc-Q_zkyRoU 2023-04-05 0.8 https://oncologypodcast.simplecast.com/episodes/experts-discuss-claudin-182-a-new-target-for-precision-care-of-gastric-and-gastroesophageal-cancers-pfH9ZnEr 2023-03-28 0.8 https://oncologypodcast.simplecast.com/episodes/treatment-considerations-for-patients-with-essential-thrombocythemia-a-conversation-between-experts-z_fY4B5K 2023-02-23 0.8 https://oncologypodcast.simplecast.com/episodes/faqs-on-asparaginase-for-all-wHRyWb_i 2023-02-20 0.8 https://oncologypodcast.simplecast.com/episodes/experts-answer-questions-on-the-management-of-patients-with-t-cell-lymphomas-SFxD42GY 2023-02-17 0.8 https://oncologypodcast.simplecast.com/episodes/experts-answer-questions-on-personalized-management-of-patients-with-myelodysplastic-syndromes-_vFSsG8C 2023-02-17 0.8 https://oncologypodcast.simplecast.com/episodes/treatment-of-tnbc-J9UYpLIf 2023-01-18 0.8 https://oncologypodcast.simplecast.com/episodes/treatment-of-pv-ppCBCr8O 2023-01-11 0.8 https://oncologypodcast.simplecast.com/episodes/hcc-surveillance-byIb84N0 2023-01-03 0.8 https://oncologypodcast.simplecast.com/episodes/a-patients-perspective-on-effective-communication-with-the-healthcare-team-my-journey-with-high-risk-hr-positive-her2-negative-early-breast-cancer-0hviuhtr 2022-12-13 0.8 https://oncologypodcast.simplecast.com/episodes/the-transgender-cancer-experience-a-conversation-between-an-oncologist-and-a-transmasculine-individual-on-navigating-the-healthcare-system-o0_gHJfp 2022-11-29 0.8 https://oncologypodcast.simplecast.com/episodes/esgo-2022-Bvb4CIz2 2022-11-29 0.8 https://oncologypodcast.simplecast.com/episodes/evolving-role-of-btk-inhibitors-in-cll-experts-answer-your-questions-_BRcNlu7 2022-11-09 0.8 https://oncologypodcast.simplecast.com/episodes/btki-therapy-for-cll-mcl-soho-2022-fQDHu00l 2022-10-28 0.8 https://oncologypodcast.simplecast.com/episodes/relapsed-refractory-myeloma-navigating-the-complex-treatment-landscape-hvBvrAcd 2022-10-24 0.8 https://oncologypodcast.simplecast.com/episodes/expert-thoughts-on-key-trials-of-interest-for-ovarian-and-cervical-cancer-at-the-igcs-2022-annual-global-meeting-WyXzJpk5 2022-10-24 0.8 https://oncologypodcast.simplecast.com/episodes/esmo-2022-oc-updates-YMclK1s5 2022-10-04 0.8 https://oncologypodcast.simplecast.com/episodes/faqs-on-egfr-mutated-nsclc-DIH_CdfY 2022-09-28 0.8 https://oncologypodcast.simplecast.com/episodes/new-evidence-with-btk-inhibitor-therapy-in-cll-and-mcl-from-the-pan-pacific-lymphoma-conference-2022-6BQKXI1R 2022-08-30 0.8 https://oncologypodcast.simplecast.com/episodes/challenges-in-hcc-Nxgj_Ttt 2022-08-22 0.8 https://oncologypodcast.simplecast.com/episodes/her2-positive-breast-cancer-current-approaches-for-quality-care-eU3ECzSc 2022-09-13 0.8 https://oncologypodcast.simplecast.com/episodes/btki-therapy-for-cll-and-mcl-eha-2022-8UgqmNwj 2022-07-21 0.8 https://oncologypodcast.simplecast.com/episodes/btki-therapy-for-cll-and-mcl-asco-2022-U8lm_f58 2022-07-06 0.8 https://oncologypodcast.simplecast.com/episodes/asco-2022-gynonc-zgRW4rUM 2022-06-30 0.8 https://oncologypodcast.simplecast.com/episodes/sgo-2022-gynonc-POPmYCyr 2022-05-19 0.8 https://oncologypodcast.simplecast.com/episodes/trans-care-call-to-action-dhs_m0w7 2022-05-13 0.8 https://oncologypodcast.simplecast.com/episodes/patient-transition-story-podcast-44Hz2Vzu 2022-05-02 0.8 https://oncologypodcast.simplecast.com/episodes/anti-tigit-therapy-px1r93ON 2022-04-15 0.8 https://oncologypodcast.simplecast.com/episodes/targeting-tigit-Hq7wKUwV 2022-04-07 0.8 https://oncologypodcast.simplecast.com/episodes/evolving-treatment-landscape-with-regorafenib-and-tas-102-in-metastatic-colorectal-cancer-IgdH3B8K 2022-04-06 0.8 https://oncologypodcast.simplecast.com/episodes/btki-faq-qMMrAA9G 2022-03-31 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-optimal-current-management-of-patients-with-cholangiocarcinoma-KKEXAhce 2022-03-21 0.8 https://oncologypodcast.simplecast.com/episodes/cancer-conversations-3-case-challenges-of-real-patients-with-myelodysplastic-syndromes-UwFbIuYV 2022-03-14 0.8 https://oncologypodcast.simplecast.com/episodes/targeted-tx-for-advsm-O4OhP_fe 2022-03-10 0.8 https://oncologypodcast.simplecast.com/episodes/advances-in-b-cell-lymphomas-ZXvuez_u 2022-02-25 0.8 https://oncologypodcast.simplecast.com/episodes/tkis-for-advanced-hcc-in-the-second-line-and-beyond-6S4PilLV 2022-02-22 0.8 https://oncologypodcast.simplecast.com/episodes/new-directions-with-parp-inhibitors-in-pancreatic-cancer-sDId0ED6 2022-03-18 0.8 https://oncologypodcast.simplecast.com/episodes/myeloma-patient-case-examples-mRvNlrbj 2022-02-18 0.8 https://oncologypodcast.simplecast.com/episodes/advances-in-itp-V6YgSLgd 2022-02-07 0.8 https://oncologypodcast.simplecast.com/episodes/precision-medicine-for-attp-expert-answers-to-your-questions-n2R2tTA2 2022-02-01 0.8 https://oncologypodcast.simplecast.com/episodes/t-cell-lymphoma-qa-l8HCyPKt 2022-01-31 0.8 https://oncologypodcast.simplecast.com/episodes/multidisciplinary-overview-of-iegfr-i-mutated-nsclc-an-expert-panel-discussion-from-biomarker-testing-to-managing-progressive-disease-cqbXQjQJ 2022-01-26 0.8 https://oncologypodcast.simplecast.com/episodes/experts-answer-questions-on-current-and-emerging-options-for-hemophilia-a-management-2giTphqT 2022-01-14 0.8 https://oncologypodcast.simplecast.com/episodes/strategies-for-secondary-aml-and-emerging-therapies-for-aml-tdRjOcyR 2022-01-10 0.8 https://oncologypodcast.simplecast.com/episodes/induction-and-maintenance-therapy-for-fit-patients-with-aml-without-targetable-mutations-wlX7veeA 2022-01-10 0.8 https://oncologypodcast.simplecast.com/episodes/targeted-treatment-options-for-patients-with-aml-and-flt3-or-idh1-2-mutations-wDJnQwxz 2022-01-10 0.8 https://oncologypodcast.simplecast.com/episodes/an-overview-of-aml-and-treatment-strategies-for-patients-unfit-for-intensive-therapy-7bQ1uIem 2022-01-10 0.8 https://oncologypodcast.simplecast.com/episodes/higher-risk-and-r-r-mds-y8F9ctng 2021-12-22 0.8 https://oncologypodcast.simplecast.com/episodes/lower-risk-mds-Wf14CFWm 2021-12-22 0.8 https://oncologypodcast.simplecast.com/episodes/key-factors-in-later-line-crc-tx-qP_HkORG 2021-12-20 0.8 https://oncologypodcast.simplecast.com/episodes/the-evolving-role-of-tkis-in-first-line-treatment-of-advanced-hcc-TNhxY_SX 2021-12-14 0.8 https://oncologypodcast.simplecast.com/episodes/esgo-2021-gynonc-6QJyy7Y1 2021-12-01 0.8 https://oncologypodcast.simplecast.com/episodes/faq-nsclc-immunotherapy-XK637H7W 2021-12-01 0.8 https://oncologypodcast.simplecast.com/episodes/2nd-gen-trk-inhibitors-1h11YOHp 2021-11-09 0.8 https://oncologypodcast.simplecast.com/episodes/tkis-in-sarcoma-vIiNrTa2 2021-11-02 0.8 https://oncologypodcast.simplecast.com/episodes/parpis-in-pancreatic-cancer-g2mqhBWF 2021-11-03 0.8 https://oncologypodcast.simplecast.com/episodes/dosing-in-later-line-crc-tx-xpfGlqAl 2021-10-21 0.8 https://oncologypodcast.simplecast.com/episodes/new-data-on-covid-19-_7N6C0BC 2021-10-15 0.8 https://oncologypodcast.simplecast.com/episodes/parp-inhibitors-in-ovarian-cancer-experts-discuss-patient-cases-and-the-current-paradigm-mGjgdrxa 2021-10-14 0.8 https://oncologypodcast.simplecast.com/episodes/counseling-patients-and-caregivers-on-prophylaxis-therapy-for-severe-hemophilia-a-_dnxueto 2021-10-08 0.8 https://oncologypodcast.simplecast.com/episodes/ntrk-testing-Rr9vC8YL 2021-10-08 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-hcp-questions-on-androgen-deprivation-therapy-for-prostate-cancer-jqAF3fc9 2021-11-02 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-important-clinical-trial-data-from-esmo-2021-informing-treatment-for-endometrial-and-ovarian-cancer-49V8PGaD 2021-09-29 0.8 https://oncologypodcast.simplecast.com/episodes/using-hiv-assist-to-guide-art-switch-in-a-patient-with-chronic-kidney-disease-_ma4mtps 2021-09-28 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-practice-changing-from-igcs-2021-informing-treatment-for-endometrial-ovarian-and-cervical-cancer-gk4eIPFe 2021-09-21 0.8 https://oncologypodcast.simplecast.com/episodes/myeloma-treatment-choices-faqs-_upEUHRH 2021-08-24 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-optimal-use-of-cdk4-6-inhibitors-for-hr-positive-her2-negative-breast-cancer-CCDcjtU5 2021-08-19 0.8 https://oncologypodcast.simplecast.com/episodes/gi-cancer-biomarker-testing-KOq2SA4w 2021-08-18 0.8 https://oncologypodcast.simplecast.com/episodes/cdk4-6-inhibitors-in-early-stage-hr-her2-breast-cancer-expert-answers-to-clinician-questions-i4wfvcIR 2021-08-05 0.8 https://oncologypodcast.simplecast.com/episodes/the-latest-advances-and-guidance-in-nonmetastatic-castration-resistant-prostate-cancer-NeZl3WOg 2021-07-30 0.8 https://oncologypodcast.simplecast.com/episodes/managing-serious-adverse-events-associated-with-btk-inhibitor-treatment-JTFj9DxN 2021-07-27 0.8 https://oncologypodcast.simplecast.com/episodes/strategies-for-avoiding-adverse-reactions-to-btk-inhibitor-therapy-part-2-patient-strategies-for-self-management-j60DQ850 2021-07-27 0.8 https://oncologypodcast.simplecast.com/episodes/ned-talk-avoiding-btki-aes-part-1-GZrhdiDo 2021-07-27 0.8 https://oncologypodcast.simplecast.com/episodes/ned-talk-btki-overview-tDiDD2RH 2021-07-23 0.8 https://oncologypodcast.simplecast.com/episodes/ned-talk-btki-aes-qz4kpjPK 2021-07-27 0.8 https://oncologypodcast.simplecast.com/episodes/radiopharmaceuticals-in-the-treatment-of-metastatic-castration-resistant-prostate-cancer-s7AGRZMN 2021-07-20 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-hcp-questions-on-car-t-cell-therapy-ENknaF4R 2021-07-19 0.8 https://oncologypodcast.simplecast.com/episodes/how-to-integrate-novel-treatment-classes-for-r-r-myeloma-into-clinical-practice-information-on-bcma-targeted-therapies-s_65_6wq 2021-07-27 0.8 https://oncologypodcast.simplecast.com/episodes/how-to-integrate-novel-treatment-classes-for-r-r-myeloma-into-clinical-practice-information-on-selinexor-venetoclax-and-melphalan-flufenamide-afP2oiNW 2021-07-16 0.8 https://oncologypodcast.simplecast.com/episodes/ned-talk-newly-diagnosed-myeloma-care-irUkIhUl 2021-07-14 0.8 https://oncologypodcast.simplecast.com/episodes/ned-talk-mm-tx-after-first-relapse-CHyMEBTr 2021-07-14 0.8 https://oncologypodcast.simplecast.com/episodes/precision-medicine-in-gynecologic-cancers-expert-answers-to-your-questions-ADIb_6gK 2021-07-12 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-questions-on-managing-neurofibromatosis-type-1-and-mek-inhibitors-for-nf1-associated-plexiform-neurofibromas-R_aiEGGz 2021-07-12 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-questions-on-parp-inhibitor-combinations-in-prostate-cancer-i3smjpoz 2021-06-30 0.8 https://oncologypodcast.simplecast.com/episodes/immunotherapy-for-advanced-hcc-current-options-and-expert-answers-to-clinician-questions-k2U9Cacq 2021-06-29 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-key-data-from-asco-2021-informing-treatment-for-endometrial-ovarian-and-cervical-cancer-lYv4sAHD 2021-06-24 0.8 https://oncologypodcast.simplecast.com/episodes/optimizing-therapy-for-relapsed-refractory-multiple-myeloma-expert-answers-to-your-questions-vsdpok6J 2021-06-17 0.8 https://oncologypodcast.simplecast.com/episodes/experts-answer-faqs-on-biomarker-driven-therapy-for-non-small-cell-lung-cancer-nupX1Fki 2021-05-19 0.8 https://oncologypodcast.simplecast.com/episodes/adcs-in-nsclc-post-elcc-EDX5YlEg 2021-05-18 0.8 https://oncologypodcast.simplecast.com/episodes/immunotherapy-for-advanced-hcc-case-series-utQ_0g1o 2021-05-17 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-germany-QrmbaaTW 2021-05-13 0.8 https://oncologypodcast.simplecast.com/episodes/managing-toxicities-associated-with-fgfr-inhibitors-in-urothelial-cancer-and-beyond-h8f6LlSk 2021-05-04 0.8 https://oncologypodcast.simplecast.com/episodes/optimizing-the-timing-and-sequencing-of-regorafenib-and-tas-102-for-patients-with-metastatic-colorectal-cancer-DiNaXgck 2021-04-28 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-questions-on-contemporary-management-of-multiple-myeloma-yR32A7SB 2021-04-22 0.8 https://oncologypodcast.simplecast.com/episodes/combining-parp-inhibitors-with-other-treatments-for-men-with-prostate-cancer-clinical-trial-updates-0pjwwKmX 2021-04-19 0.8 https://oncologypodcast.simplecast.com/episodes/rationale-parpi-combinations-S7LzyQww 2021-04-15 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insight-on-key-data-from-sgo-2021-informing-treatment-for-endometrial-and-ovarian-cancer-7FRzjQei 2021-04-08 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-questions-on-parp-inhibition-for-prostate-cancer-lPVGVjbX 2021-04-06 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-highlights-from-ash-2020-on-lymphomas-cll-BR0y1CTA 2021-03-26 0.8 https://oncologypodcast.simplecast.com/episodes/improving-outcomes-in-egfr-mutated-non-small-cell-lung-cancer-global-insights-on-evolving-practice-standards-YQ0NIZiK 2021-03-31 0.8 https://oncologypodcast.simplecast.com/episodes/targeting-fgfr-in-urothelial-cancer-and-beyond-Fqi6kg_P 2021-04-30 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-hcp-questions-on-pancreatic-cancer-treatment-dNPvfEwU 2021-03-22 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-hcp-questions-on-car-t-cell-therapies-in-lymphoma-u0ART4Lo 2021-03-18 0.8 https://oncologypodcast.simplecast.com/episodes/frequently-asked-questions-on-emerging-antibodydrug-conjugates-in-the-treatment-of-advanced-non-small-cell-lung-cancer-iuu8k_Aq 2021-03-17 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-hcp-questions-on-car-t-cell-therapies-in-myeloma-and-management-of-key-toxicities-V06ljD7f 2021-03-12 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-highlights-from-ash-2020-on-multiple-myeloma-rKlRW92v 2021-03-12 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-key-data-from-ash-2020-on-acute-and-chronic-leukemias-ch_48UCn 2021-02-26 0.8 https://oncologypodcast.simplecast.com/episodes/wqwkr6w4-RFGfLJPq 2021-02-24 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-argentina-gX62coe_ 2021-03-02 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-key-data-from-ash-2020-on-nonmalignant-hematologic-disorders-stYST1l4 2021-02-10 0.8 https://oncologypodcast.simplecast.com/episodes/expert-insights-on-key-data-from-ash-2020-on-myelodysplastic-syndromes-and-myeloproliferative-neoplasms-mHfO0f2f 2021-02-10 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-questions-on-contemporary-management-of-hemophilia-a-5NW3ikkZ 2021-02-04 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-italy-8MOSZ4dr 2021-02-04 0.8 https://oncologypodcast.simplecast.com/episodes/ici-in-uc-united-states-rersZJRU 2021-02-01 0.8 https://oncologypodcast.simplecast.com/episodes/icis-for-hcc-overview-hD6m2d_R 2021-01-19 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-spain-NJURjtUL 2021-01-08 0.8 https://oncologypodcast.simplecast.com/episodes/expert-answers-to-pathologist-questions-on-new-biomarkers-for-precision-therapy-in-lung-cance-GcI9pEKY 2020-12-28 0.8 https://oncologypodcast.simplecast.com/episodes/application-of-individualized-treatment-for-cll-sll-novel-agents-combinations-and-sequencing-therapy-faq-hX3Ah_Lb 2020-12-24 0.8 https://oncologypodcast.simplecast.com/episodes/practical-insights-on-key-data-from-esmo-2020-informing-precision-medicine-in-nsclc-wHF1c8tt 2020-12-21 0.8 https://oncologypodcast.simplecast.com/episodes/immunotherapy-for-advanced-hcc-experts-answer-clinician-questions-KsIS3xQn 2020-12-17 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-the-netherlands-and-the-united-kingdom-prCYxCFP 2020-11-20 0.8 https://oncologypodcast.simplecast.com/episodes/incorporating-immune-checkpoint-inhibitors-into-practice-for-advanced-urothelial-cancer-expert-perspectives-from-france-iWqBJNWY 2020-11-19 0.8 https://oncologypodcast.simplecast.com/episodes/molecular-classification-of-endometrial-carcinoma-in-the-clinic-today-SERq1C_0 2020-11-11 0.8 https://oncologypodcast.simplecast.com/episodes/ec-immunotherapy-ZGOVkOiD 2020-11-11 0.8 https://oncologypodcast.simplecast.com/episodes/biomarkers-in-ovarian-cancer-expert-discussion-of-options-for-first-line-maintenance-therapy-B1CPmKSj 2020-10-02 0.8 https://oncologypodcast.simplecast.com/episodes/developments-in-acute-leukemias-expert-answers-to-clinician-questions-QEU2KtAQ 2020-10-02 0.8 https://oncologypodcast.simplecast.com/episodes/biomarkers-in-ovarian-cancer-expert-discussion-of-brca-testing-and-beyond-el9WaXcY 2020-10-07 0.8 https://oncologypodcast.simplecast.com/episodes/experts-discuss-evolving-state-of-the-art-management-of-patients-with-her2-positive-mbc-WrxUq43K 2020-09-21 0.8 https://oncologypodcast.simplecast.com/episodes/the-art-of-medicine-clinical-considerations-for-patients-with-advanced-rcc-hDxXLRoZ 2020-09-21 0.8 https://oncologypodcast.simplecast.com/episodes/chronic-lymphocytic-leukemia-new-horizons-with-btk-inhibitors-faq-part-1-_oPZ_XVp 2020-09-17 0.8 https://oncologypodcast.simplecast.com/episodes/chronic-lymphocytic-leukemia-new-horizons-with-btk-inhibitors-faq-part-3-hehNZETs 2020-09-17 0.8 https://oncologypodcast.simplecast.com/episodes/clinical-considerations-for-iret-i-fusionpositive-nsclc-6EcCxO6N 2020-09-17 0.8 https://oncologypodcast.simplecast.com/episodes/chronic-lymphocytic-leukemia-new-horizons-with-btk-inhibitors-faq-part-2-XwuhOEMr 2020-09-16 0.8 https://oncologypodcast.simplecast.com/episodes/car-t-faq-y_RoZlEK 2020-09-14 0.8 https://oncologypodcast.simplecast.com/episodes/practical-application-of-immuno-oncology-in-rcc-expert-discussion-of-second-line-therapy-and-beyond-Q4jHmb1z 2020-09-14 0.8 https://oncologypodcast.simplecast.com/episodes/faq-on-new-therapeutic-developments-in-relapsed-refractory-multiple-myeloma-hGwHyeOW 2020-09-03 0.8 https://oncologypodcast.simplecast.com/episodes/new-advances-in-relapsed-refractory-multiple-myeloma-frequently-asked-questions-on-current-and-emerging-treatments-7nw0l1or 2020-09-01 0.8 https://oncologypodcast.simplecast.com/episodes/rcc-io-frontline-therapy-3CxKsIxz 2020-08-31 0.8 https://oncologypodcast.simplecast.com/episodes/wm-and-lymphoma-report-asco-eha-2020-biGQmEDM 2020-08-31 0.8 https://oncologypodcast.simplecast.com/episodes/metex14-nsclc-faq-part-1-_2UPzugc 2020-08-28 0.8 https://oncologypodcast.simplecast.com/episodes/metex14-nsclc-faq-part-2-jC5IxTfi 2020-08-28 0.8 https://oncologypodcast.simplecast.com/episodes/faq-immunotherapy-in-sclc-J_u_KAZm 2020-08-27 0.8 https://oncologypodcast.simplecast.com/episodes/cll-report-asco-eha-2020-inxuCwMV 2020-08-26 0.8 https://oncologypodcast.simplecast.com/episodes/future-aml-therapy-vqXKZvfX 2020-08-14 0.8 https://oncologypodcast.simplecast.com/episodes/trk-inhibitors-faq-fKzldww7 2020-08-14 0.8 https://oncologypodcast.simplecast.com/episodes/faq-improving-cml-therapy-rVIkLdCd 2020-08-13 0.8 https://oncologypodcast.simplecast.com/episodes/faq-biomarker-testing-targeted-tx-f6MPme_L 2020-08-10 0.8 https://oncologypodcast.simplecast.com/episodes/io-biomarkers-qa-session-JgkEgfe_ 2020-08-10 0.8 https://oncologypodcast.simplecast.com/episodes/faq-ici-biomarkers-j428UrFu 2020-08-12 0.8 https://oncologypodcast.simplecast.com/episodes/experts-discuss-adcs-for-her2-negative-ultralow-low-mbc-rXxfzGFZ/transcript 2026-04-02 0.7 https://oncologypodcast.simplecast.com/episodes/advanced-practice-professionals-on-biomarker-testing-in-patients-with-solid-tumors-colorectal-cancer-H9QtAE7a/transcript 2026-03-24 0.7 https://oncologypodcast.simplecast.com/episodes/advanced-practice-professionals-on-biomarker-testing-in-patients-with-solid-tumors-prostate-cancer-gPEubEaL/transcript 2026-03-24 0.7 https://oncologypodcast.simplecast.com/episodes/bladder-cancer-breakthroughs-new-nmibc-therapies-and-ev-pembrolizumab-updates-from-asco-gu-2026-VT2A9cW5/transcript 2026-03-23 0.7 https://oncologypodcast.simplecast.com/episodes/myth-vs-medicine-pharmacists-perspective-on-adjuvant-cdk4-6-inhibitor-optimization-EWbEJ_1v/transcript 2026-03-12 0.7 https://oncologypodcast.simplecast.com/episodes/2025-sabcs-cf-highlights-_U7HKSWV/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/advancing-kras-g12c-targeted-therapies-in-nsclc-current-evidence-and-future-directions-b5W8lj1w/transcript 2026-04-08 0.7 https://oncologypodcast.simplecast.com/episodes/ras-inhibitors-for-pdac-lY5Ir7hc/transcript 2026-02-23 0.7 https://oncologypodcast.simplecast.com/episodes/biomarker-testing-lung-cancer-96hfRekH/transcript 2026-04-07 0.7 https://oncologypodcast.simplecast.com/episodes/celmod-agents-in-mm-t__Fv414/transcript 2026-02-27 0.7 https://oncologypodcast.simplecast.com/episodes/pulsecast-mds-mpns-ash-2025-gjgMSLvH/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-multiple-myeloma-from-the-2025-ash-annual-meeting-8QYrWSjK/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-lymphomas-from-the-2025-ash-annual-meeting-81opm6P_/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-nonmalignant-blood-disorders-from-the-2025-ash-annual-meeting-zWdQzhSF/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/pulsecast-highlights-in-leukemias-from-the-2025-ash-annual-meeting-skBpct_b/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/new-targeted-combination-for-lgsoc-4wKKnX5N/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/cdh6-adcs-GtXXAtTO/transcript 2026-03-27 0.7 https://oncologypodcast.simplecast.com/episodes/immunotherapy-in-cscc-_r1fTTyb/transcript 2026-03-11 0.7 https://oncologypodcast.simplecast.com/episodes/modern-management-of-pnh-CVZ8PPvL/transcript 2026-03-26 0.7 https://oncologypodcast.simplecast.com/episodes/ebc-care-6ZFtVPLf/transcript 2026-02-17 0.7 https://oncologypodcast.simplecast.com/episodes/mbc-care-lWQSrK4f/transcript 2026-02-17 0.7 https://oncologypodcast.simplecast.com/episodes/treatment-of-her2pos-gea-and-btc-rQi8W8yC/transcript 2026-02-27 0.7 https://oncologypodcast.simplecast.com/episodes/pancreatic-cancer-progress-podcast-QbbAcnf_/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/cdk46-inhibitors-in-breast-cancer-zXtfYqrf/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/targeting-dll3-for-ep-necs-rnBn0K9t/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/subcutaneous-io-podcast-cbwpysxW/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/nhl-all-from-eha-icml-2025-0iB6gGNT/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/her2-positive-mbc-new-options-hkcRyxCI/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/immunotherapy-for-hcc-z9_qLkwS/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/hodkin-lymphoma-frontline-tx-k3Eik1yd/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/celmods-in-myeloma-08Po1z_N/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/her2-adcs-safety-and-tolerability-RNLUQdZr/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/her2-targeted-adcs-clinical-data-GObe0J_L/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/her2-targeted-adcs-in-solid-tumors-hmyHtaoK/transcript 2026-02-03 0.7 https://oncologypodcast.simplecast.com/episodes/1l-her2-positive-mbc-u6mKk8Hu/transcript 2026-02-03 0.7